Clinical and epidemiological profile of multiple sclerosis in a reference center in the State of Bahia, Brazil

Arquivos de Neuro-Psiquiatria

Volumn 64, Issue 3 B, 2006, Pages 727-730

  Cardoso, Eduardo ^a,b,c   Fukuda, Thiago ^a   Pereira, Júlio ^a   Seixas, Jamile ^a   Miranda, Rafael ^a   Rodrigues, Bernardo ^a   Saback, Thaís ^a   Andrade, Renata ^a   Cardoso, Grace ^a   Martinez, Rosa ^d   Avena, Juliane ^d   Melo, Ailton ^a,c,d  

^a FEDERAL UNIVERSITY OF BAHIA   (Brazil)

^b DEPARTAMENTO DE CIÊNCIAS BIOLÓGICAS   (Brazil)

^c Brazilian Committee for Treatment and Research in Multiple Sclerosis (BCTRIMS)   (Brazil)

^d Brazilian Committee for Treatment and Research in Multiple Sclerosis ^*

Author keywords

Epidemiology; Multiple sclerosis; Reference center

Indexed keywords

BETA1A INTERFERON; GLATIRAMER; IMMUNOMODULATING AGENT; INTERFERON BETA SERINE;

ADULT; ARTICLE; BRAZIL; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE SEVERITY; EPIDEMIOLOGICAL DATA; ETHNIC DIFFERENCE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; PREVALENCE; PROGNOSIS;

EID: 33750261115     PISSN: 0004282X     EISSN: 16784227     Source Type: Journal    
DOI: 10.1590/S0004-282X2006000500005     Document Type: Article

References (18)

1. Noseworthy JH, Lucchinetti C, Rodriguez M, Weinshenker BG. Multiple sclerosis. N Engl J Med 2000;343:938-951.
2. Kurtzke JF, Page WF. Epidemiology of multiple sclerosis in US veterans: VII. Risk factors for MS. Neurology 1997;48:204-213
3. Compston A, Coles A. Multiple sclerosis. Lancet 2002; 359:1221-1231.
4. Arruda WO, Scola RH, Teive HAG, Werneck LC. Multiple sclerosis: report on 200 cases from Curitiba, Southern Brazil and comparison with other Brazilian series. Arq Neuropsiquiatr 2001;59:165-170.
5. Callegaro D. Contribuição ao estudo clínico evolutivo da esclerose múltipla: análise de 120 pacientes. Tese. Universidade de São Paulo. São Paulo, 1989.
6. Ferreira ML, Machado MI, Vilela ML, et al. Epidemiology of 118 cases of multiple sclerosis after 15 years of follow-up on the reference center of Hospital da Restauracao, Recife, Pernambuco, Brazil. Arq Neuropsiquiat 2004;62:1027-1032.
7. Lana-Peixoto M, Lana-Peixoto MIV. Is multiple sclerosis in Brazil and Asia alike? Arq Neuropsiquiatr 1992;50:119-125.
8. Leite ACCB, Andrade C, Novis S. Esclerose múltipla no Rio de Janeiro: apresentação clínica em 51 casos. Arq Neuropsiquiatr 1990;48(Supl):S66.
9. Moreira MA, Felipe E, Mendes MF, Tilbery CP. Esclerose múltipla: estudo descritivo de suas formas clínicas em 302 casos. Arq Neuropsiquiatr 2000;58:460-466.
10. Oliveira EML, Annes M, Oliveira ASB, Gabbai AA. Esclerose múltipla: estudo clínico de 50 pacientes acompanhados no Ambulatório de Neurologia UNIFESP-EPM. Arq Neuropsiquiatr 1999;57:51-55.
11. Papais-Alvarenga RM, Santos CMM, Abreu JS, et al. Esclerose múltipla: perfil clínico e evolutivo no município do Rio de Janeiro. Rev Bras Neurol 1995;31:75-87.
12. Tilbery CP, Felipe E, Moreira MA, Mendes MF, França AS. Interferon beta-1a na esclerose múltipla: experiência de um ano em 62 pacientes. Arq Neuropsiquiatr 2000;58:452-459.
13. Cardoso E, Fukuda T, Melo A, et al. Epidemiologia da esclerose múltipla no Estado da Bahia. Arq Neuropsiquiatr 2005;63(Supl 1):S18.
14. Foster RM, Harries JR. Multiple sclerosis in the African. Br Med J 1970;3:628.
15. Ames FR, Bowen RM. First coloured South African with multiple sclerosis confirmed by necropsy. J Neurol Neurosurg Psychiatry 1979;42:731-733.
16. Kioy PG. Emerging picture of multiple sclerosis in Kenya. East Afr Med J 2000;78:93-96.
17. Modi G, Mochan A, Modi M, Saffer D. Demyelinating disorder of the central nervous system occurring in black South Africans. J Neurol Neurosurg Psychiatry 2001;70:500-505.
18. Cree BAC, Khan O, Bourdette D, et al. Clinical characteristics of African Americans vs Caucasian Americans with multiple sclerosis. Neurology 2004;63:2039-2045.